Projects
BIO-7892 Phase III Chronic Idiopathic Urticaria Study
Active
A randomized, double-blind, placebo-controlled Phase III trial evaluating the efficacy and safety of BIO-7892 in adult patients with chronic idiopathic urticaria inadequately controlled by antihistamines.